Health Catalyst, Inc.·4

Sep 3, 9:00 PM ET

HAQUE PROMOD 4

4 · Health Catalyst, Inc. · Filed Sep 3, 2019

Insider Transaction Report

Form 4
Period: 2019-09-01
HAQUE PROMOD
Director10% Owner
Transactions
  • Award

    Common Stock

    2019-09-01+3,5573,557 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    2,952,091
  • Common Stock

    (indirect: See Footnote)
    2,952,090
Footnotes (3)
  • [F1]Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the date of the next Annual Meeting of the Issuer's Stockholders.
  • [F2]The securities shown on Line 2 of Table I represent securities held of record by Norwest Venture Partners XI, LP ("NVP XI"). By virtue of his position as a Co-Chief Executive Officer of NVP Associates, LLC ("NVP Associates"), the managing member of the general partner of NVP XI, Promod Haque may be deemed to share voting and dispositive power with respect to such securities. Mr. Haque disclaims beneficial ownership of all such securities, except to the extent of any pecuniary interest therein.
  • [F3]The securities shown on Line 3 of Table I represent securities held of record by Norwest Venture Partners XII, LP ("NVP XII"). By virtue of his position as a Co-Chief Executive Officer of NVP Associates, LLC ("NVP Associates"), the managing member of the general partner of NVP XII, Promod Haque may be deemed to share voting and dispositive power with respect to such securities. Mr. Haque disclaims beneficial ownership of all such securities, except to the extent of any pecuniary interest therein.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION